Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:endometrial adenocarcinoma incidence/prevalence measurement
go back to main search page
Accession:CMO:0001789 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display endometrial adenocarcinomas at a point in time or develop endometrial adenocarcinomas within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. An endometrial adenocarcinoma is an abnormal and malignant growth of the epithelial cells of the mucous membrane lining the uterus that results from uncontrolled, progressive multiplication of cells, serves no physiological function, and forms or appears to form glandular structures.
Synonyms:related_synonym: endometrioid carcinoma incidence/prevalence measurement
 xref: MESH:D018269



show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    tumor measurement 88
      tumor incidence/prevalence measurement 16
        endometrial adenocarcinoma incidence/prevalence measurement 0
          percentage of study population developing endometrial adenocarcinomas during a period of time 0
          percentage of study population displaying endometrial adenocarcinomas at a point in time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          organ tumorous lesion incidence/prevalence measurement 18
            tumor incidence/prevalence measurement 16
              endometrial adenocarcinoma incidence/prevalence measurement 0
                percentage of study population developing endometrial adenocarcinomas during a period of time 0
                percentage of study population displaying endometrial adenocarcinomas at a point in time 0
paths to the root